Intelligence / Healthtech / De Novo Grants / Epi-Minder Pty, Ltd.
Approvalsnovel device granted (FDA De Novo)17 Apr 2025
Epi-Minder Pty, Ltd.
17 Apr 2025: Novel device granted (FDA De Novo) · Minder System. Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 17 Apr 2025
- Device
- Minder System
- Specialty
- Neurology
- Product Code
- SEM
- Country
- Australia
- Location
- Melbourne, Australia
- Submitted
- 2024-10-18
- Reference
- DEN240062
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Epi-Minder Pty, Ltd.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Epi-Minder Pty, Ltd. in our registers.
More in Neurology
De Novo Grants
21 AugMatap Ii, LLCnovel device granted (FDA De Novo) · AvuluxApprovals8 MayNeurovalens Limitednovel device granted (FDA De Novo) · Modius SperoApprovals3 AprAutomated Imaging Diagnostics, LLCnovel device granted (FDA De Novo) · neuropacsApprovals14 NovFusmobile, Inc.novel device granted (FDA De Novo) · Neurolyser XR (NXR100)Approvals6 OctPainchek Limited (Ltd.)novel device granted (FDA De Novo) · PainChek (PainChek Adult)Approvals20 AugQuantalx Neuroscience, Ltd.novel device granted (FDA De Novo) · Delphi-MD SystemApprovals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.